United States Nanopharmaceuticals Market Report 2017

October 2017 | 120 pages | ID: U77526AF99BPEN
QYResearch

Abstracts

In this report, the United States Nanopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Nanopharmaceuticals in these regions, from 2012 to 2022 (forecast).

United States Nanopharmaceuticals market competition by top manufacturers/players, with Nanopharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• Pfizer
• Novartis
• Abbott
• GlaxoSmithKline
• Roche
• Sanofi
• Eli Lilly
• Astrazeneca
• Johnson & Johnson
• Celgene
• Novavax
• Stryker
• Gilead Sciences
• OSI Pharmaceuticals
• Kadmon Pharmaceuticals
• Samyang Biopharm
• Mitsubishi Pharma
• Kaken Pharmaceutical
• Selecta Biosciences
• Par Pharmaceutical
• Cerulean Pharma
• Navidea Biopharmaceuticals
• Lummy

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Liposomes
• Polymeric Micelles
• Solid Lipid Nanoparticles
• Microemulsion And Nanoemulsion
• Nanosuspension

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Nanopharmaceuticals for each application, including

• Cancer
• Tumor
• Autoimmune Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Nanopharmaceuticals Market Report 2017

1 NANOPHARMACEUTICALS OVERVIEW

1.1 Product Overview and Scope of Nanopharmaceuticals
1.2 Classification of Nanopharmaceuticals by Product Category
  1.2.1 United States Nanopharmaceuticals Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Nanopharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Liposomes
  1.2.4 Polymeric Micelles
  1.2.5 Solid Lipid Nanoparticles
  1.2.6 Microemulsion And Nanoemulsion
  1.2.7 Nanosuspension
1.3 United States Nanopharmaceuticals Market by Application/End Users
  1.3.1 United States Nanopharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cancer
  1.3.3 Tumor
  1.3.4 Autoimmune Disorders
1.4 United States Nanopharmaceuticals Market by Region
  1.4.1 United States Nanopharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Nanopharmaceuticals Status and Prospect (2012-2022)
  1.4.3 Southwest Nanopharmaceuticals Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Nanopharmaceuticals Status and Prospect (2012-2022)
  1.4.5 New England Nanopharmaceuticals Status and Prospect (2012-2022)
  1.4.6 The South Nanopharmaceuticals Status and Prospect (2012-2022)
  1.4.7 The Midwest Nanopharmaceuticals Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Nanopharmaceuticals (2012-2022)
  1.5.1 United States Nanopharmaceuticals Sales and Growth Rate (2012-2022)
  1.5.2 United States Nanopharmaceuticals Revenue and Growth Rate (2012-2022)

2 UNITED STATES NANOPHARMACEUTICALS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Nanopharmaceuticals Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Nanopharmaceuticals Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Nanopharmaceuticals Average Price by Players/Suppliers (2012-2017)
2.4 United States Nanopharmaceuticals Market Competitive Situation and Trends
  2.4.1 United States Nanopharmaceuticals Market Concentration Rate
  2.4.2 United States Nanopharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nanopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NANOPHARMACEUTICALS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Nanopharmaceuticals Sales and Market Share by Region (2012-2017)
3.2 United States Nanopharmaceuticals Revenue and Market Share by Region (2012-2017)
3.3 United States Nanopharmaceuticals Price by Region (2012-2017)

4 UNITED STATES NANOPHARMACEUTICALS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Nanopharmaceuticals Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Nanopharmaceuticals Revenue and Market Share by Type (2012-2017)
4.3 United States Nanopharmaceuticals Price by Type (2012-2017)
4.4 United States Nanopharmaceuticals Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NANOPHARMACEUTICALS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Nanopharmaceuticals Sales and Market Share by Application (2012-2017)
5.2 United States Nanopharmaceuticals Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NANOPHARMACEUTICALS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nanopharmaceuticals Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Nanopharmaceuticals Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.2 Nanopharmaceuticals Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott
  6.4.2 Nanopharmaceuticals Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
  6.5.2 Nanopharmaceuticals Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.2 Nanopharmaceuticals Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi
  6.7.2 Nanopharmaceuticals Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Eli Lilly
  6.8.2 Nanopharmaceuticals Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Astrazeneca
  6.9.2 Nanopharmaceuticals Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson
  6.10.2 Nanopharmaceuticals Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Celgene
6.12 Novavax
6.13 Stryker
6.14 Gilead Sciences
6.15 OSI Pharmaceuticals
6.16 Kadmon Pharmaceuticals
6.17 Samyang Biopharm
6.18 Mitsubishi Pharma
6.19 Kaken Pharmaceutical
6.20 Selecta Biosciences
6.21 Par Pharmaceutical
6.22 Cerulean Pharma
6.23 Navidea Biopharmaceuticals
6.24 Lummy

7 NANOPHARMACEUTICALS MANUFACTURING COST ANALYSIS

7.1 Nanopharmaceuticals Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nanopharmaceuticals

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nanopharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nanopharmaceuticals Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NANOPHARMACEUTICALS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Nanopharmaceuticals Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Nanopharmaceuticals Sales Volume Forecast by Type (2017-2022)
11.3 United States Nanopharmaceuticals Sales Volume Forecast by Application (2017-2022)
11.4 United States Nanopharmaceuticals Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Nanopharmaceuticals
Figure United States Nanopharmaceuticals Market Size (K Units) by Type (2012-2022)
Figure United States Nanopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Liposomes Product Picture
Figure Polymeric Micelles Product Picture
Figure Solid Lipid Nanoparticles Product Picture
Figure Microemulsion And Nanoemulsion Product Picture
Figure Nanosuspension Product Picture
Figure United States Nanopharmaceuticals Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Nanopharmaceuticals by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Autoimmune Disorders Examples
Table Key Downstream Customer in Autoimmune Disorders
Figure United States Nanopharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure The West Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2022)
Figure United States Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nanopharmaceuticals Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Nanopharmaceuticals Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Nanopharmaceuticals Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nanopharmaceuticals Sales Share by Players/Suppliers
Figure 2017 United States Nanopharmaceuticals Sales Share by Players/Suppliers
Figure United States Nanopharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Nanopharmaceuticals Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Nanopharmaceuticals Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nanopharmaceuticals Revenue Share by Players/Suppliers
Figure 2017 United States Nanopharmaceuticals Revenue Share by Players/Suppliers
Table United States Market Nanopharmaceuticals Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Nanopharmaceuticals Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Nanopharmaceuticals Market Share of Top 3 Players/Suppliers
Figure United States Nanopharmaceuticals Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nanopharmaceuticals Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nanopharmaceuticals Product Category
Table United States Nanopharmaceuticals Sales (K Units) by Region (2012-2017)
Table United States Nanopharmaceuticals Sales Share by Region (2012-2017)
Figure United States Nanopharmaceuticals Sales Share by Region (2012-2017)
Figure United States Nanopharmaceuticals Sales Market Share by Region in 2016
Table United States Nanopharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Nanopharmaceuticals Revenue Share by Region (2012-2017)
Figure United States Nanopharmaceuticals Revenue Market Share by Region (2012-2017)
Figure United States Nanopharmaceuticals Revenue Market Share by Region in 2016
Table United States Nanopharmaceuticals Price (USD/Unit) by Region (2012-2017)
Table United States Nanopharmaceuticals Sales (K Units) by Type (2012-2017)
Table United States Nanopharmaceuticals Sales Share by Type (2012-2017)
Figure United States Nanopharmaceuticals Sales Share by Type (2012-2017)
Figure United States Nanopharmaceuticals Sales Market Share by Type in 2016
Table United States Nanopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Nanopharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nanopharmaceuticals by Type (2012-2017)
Figure Revenue Market Share of Nanopharmaceuticals by Type in 2016
Table United States Nanopharmaceuticals Price (USD/Unit) by Types (2012-2017)
Figure United States Nanopharmaceuticals Sales Growth Rate by Type (2012-2017)
Table United States Nanopharmaceuticals Sales (K Units) by Application (2012-2017)
Table United States Nanopharmaceuticals Sales Market Share by Application (2012-2017)
Figure United States Nanopharmaceuticals Sales Market Share by Application (2012-2017)
Figure United States Nanopharmaceuticals Sales Market Share by Application in 2016
Table United States Nanopharmaceuticals Sales Growth Rate by Application (2012-2017)
Figure United States Nanopharmaceuticals Sales Growth Rate by Application (2012-2017)
Table Merck Basic Information List
Table Merck Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Nanopharmaceuticals Sales Growth Rate (2012-2017)
Figure Merck Nanopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Merck Nanopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Nanopharmaceuticals Sales Growth Rate (2012-2017)
Figure Pfizer Nanopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Pfizer Nanopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Nanopharmaceuticals Sales Growth Rate (2012-2017)
Figure Novartis Nanopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Novartis Nanopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Nanopharmaceuticals Sales Growth Rate (2012-2017)
Figure Abbott Nanopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Abbott Nanopharmaceuticals Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Nanopharmaceuticals Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Nanopharmaceuticals Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Nanopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Nanopharmaceuticals Sales Growth Rate (2012-2017)
Figure Roche Nanopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Roche Nanopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Nanopharmaceuticals Sales Growth Rate (2012-2017)
Figure Sanofi Nanopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Sanofi Nanopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Nanopharmaceuticals Sales Growth Rate (2012-2017)
Figure Eli Lilly Nanopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Eli Lilly Nanopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Astrazeneca Basic Information List
Table Astrazeneca Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astrazeneca Nanopharmaceuticals Sales Growth Rate (2012-2017)
Figure Astrazeneca Nanopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Astrazeneca Nanopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Nanopharmaceuticals Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Nanopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Nanopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Celgene Basic Information List
Table Novavax Basic Information List
Table Stryker Basic Information List
Table Gilead Sciences Basic Information List
Table OSI Pharmaceuticals Basic Information List
Table Kadmon Pharmaceuticals Basic Information List
Table Samyang Biopharm Basic Information List
Table Mitsubishi Pharma Basic Information List
Table Kaken Pharmaceutical Basic Information List
Table Selecta Biosciences Basic Information List
Table Par Pharmaceutical Basic Information List
Table Cerulean Pharma Basic Information List
Table Navidea Biopharmaceuticals Basic Information List
Table Lummy Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nanopharmaceuticals
Figure Manufacturing Process Analysis of Nanopharmaceuticals
Figure Nanopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nanopharmaceuticals Major Players/Suppliers in 2016
Table Major Buyers of Nanopharmaceuticals
Table Distributors/Traders List
Figure United States Nanopharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Nanopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Nanopharmaceuticals Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Nanopharmaceuticals Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Nanopharmaceuticals Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Nanopharmaceuticals Sales Volume (K Units) Forecast by Type in 2022
Table United States Nanopharmaceuticals Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Nanopharmaceuticals Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Nanopharmaceuticals Sales Volume (K Units) Forecast by Application in 2022
Table United States Nanopharmaceuticals Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Nanopharmaceuticals Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nanopharmaceuticals Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nanopharmaceuticals Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources